recall
saveSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls III)
community read0 votes
Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4 — Reason: Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay. — Status: Ongoing
view source ↗Data sources
last refreshed 30m ago
Found something off?
same company · ±60 days · 6
- recallSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls III)Jan 21, 2026
- approvalOLANZAPINE — FDA approvalJan 23, 2026
- approvalZYPREXA (OLANZAPINE) — FDA approvalJan 30, 2026
- approvalZYPREXA (OLANZAPINE) — FDA approvalJan 30, 2026
- recallSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls II)Feb 11, 2026
- approvalOLANZAPINE — FDA approvalMar 5, 2026
comments(0)
5-min edit window · permanent after that